122 related articles for article (PubMed ID: 25750340)
1. Role of p53 Codon72 SNP in breast cancer risk and anthracycline resistance.
Arfaoui A; Douik H; Kablouti G; Chaaben AB; Handiri N; Zid Z; Ouni N; Zouiouch F; Ayari F; Mamoughli T; Bouassida J; Abazza H; Harzallaha L; Guemira F
Anticancer Res; 2015 Mar; 35(3):1763-9. PubMed ID: 25750340
[TBL] [Abstract][Full Text] [Related]
2. MDM2 344T>A polymorphism; could it be a predictive marker of anthracycline resistance?
Arfaoui A; Douik H; Kablouti G; Chaaben A; Handiri N; Zid Z; Ouni N; Zouiouch F; Ayari F; Mamoghli T; Bouassida J; Harzallah L; Guemira F
J BUON; 2016; 21(3):732-9. PubMed ID: 27569097
[TBL] [Abstract][Full Text] [Related]
3. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
[TBL] [Abstract][Full Text] [Related]
4. P53 codon 72 polymorphism in Taiwanese breast cancer patients.
Chen FM; Ou-Yang F; Yang SF; Tsai EM; Hou MF
Kaohsiung J Med Sci; 2013 May; 29(5):259-64. PubMed ID: 23639512
[TBL] [Abstract][Full Text] [Related]
5. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.
Rogler A; Rogenhofer M; Borchardt A; Lunz JC; Knoell A; Hofstaedter F; Tannapfel A; Wieland W; Hartmann A; Stoehr R
Pathobiology; 2011; 78(4):193-200. PubMed ID: 21778786
[TBL] [Abstract][Full Text] [Related]
6. Haplotype analysis of p53 polymorphisms: Arg72Pro, Ins16bp and G13964C in Tunisian patients with familial or sporadic breast cancer.
Trifa F; Karray-Chouayekh S; Mabrouk I; Baccouche S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Cancer Epidemiol; 2010 Apr; 34(2):184-8. PubMed ID: 20233677
[TBL] [Abstract][Full Text] [Related]
7. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535
[TBL] [Abstract][Full Text] [Related]
8. TGFbeta1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFbeta1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy.
Rajkumar T; Samson M; Rama R; Sridevi V; Mahji U; Swaminathan R; Nancy NK
Breast Cancer Res Treat; 2008 Nov; 112(1):81-7. PubMed ID: 18058229
[TBL] [Abstract][Full Text] [Related]
9. Association of DNMT1 gene polymorphisms in exons with sporadic infiltrating ductal breast carcinoma among Chinese Han women in the Heilongjiang Province.
Xiang G; Zhenkun F; Shuang C; Jie Z; Hua Z; Wei J; Da P; Dianjun L
Clin Breast Cancer; 2010 Oct; 10(5):373-7. PubMed ID: 20920981
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
[TBL] [Abstract][Full Text] [Related]
11. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
12. Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case-control study.
He XF; Su J; Zhang Y; Huang X; Liu Y; Ding DP; Wang W; Arparkorn K
Breast Cancer Res Treat; 2011 Nov; 130(2):517-29. PubMed ID: 21604156
[TBL] [Abstract][Full Text] [Related]
13. LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province.
Fu Z; Jiao M; Zhang M; Xu F; Yuan W; Pang D; Li D
Breast Cancer Res Treat; 2011 May; 127(1):265-71. PubMed ID: 20953905
[TBL] [Abstract][Full Text] [Related]
14. TP53 PIN3 polymorphism associated with breast cancer risk in Iranian women.
Faghani M; Ghasemi FM; Nikhbakht M; Salehi M
Indian J Cancer; 2011; 48(3):298-302. PubMed ID: 21921327
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers.
Lehmann-Che J; André F; Desmedt C; Mazouni C; Giacchetti S; Turpin E; Espié M; Plassa LF; Marty M; Bertheau P; Sotiriou C; Piccart M; Symmans WF; Pusztai L; de Thé H
Oncologist; 2010; 15(3):246-52. PubMed ID: 20228131
[TBL] [Abstract][Full Text] [Related]
16. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies.
Zhang Z; Wang M; Wu D; Wang M; Tong N; Tian Y; Zhang Z
Breast Cancer Res Treat; 2010 Apr; 120(2):509-17. PubMed ID: 19629678
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.
Jaremko M; Justenhoven C; Schroth W; Abraham BK; Fritz P; Vollmert C; Illig T; Simon W; Schwab M; Brauch H
Pharmacogenet Genomics; 2007 Jul; 17(7):529-38. PubMed ID: 17558308
[TBL] [Abstract][Full Text] [Related]
18. p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia.
Malisic E; Jankovic R; Slavkovic D; Milovic-Kovacevic M; Radulovic S
J BUON; 2010; 15(1):101-6. PubMed ID: 20414935
[TBL] [Abstract][Full Text] [Related]
19. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
Franeková M; Zúbor P; Stanclová A; Dussan CA; Bohusová T; Galo S; Dobrota D; Kajo K; Péc M; Racay P
Neoplasma; 2007; 54(2):155-61. PubMed ID: 17319790
[TBL] [Abstract][Full Text] [Related]
20. Tumour response to preoperative anthracycline-based chemotherapy in operable breast cancer: the predictive role of p53 expression.
Mieog JS; van der Hage JA; van de Vijuer MJ; van de Velde CJ;
Eur J Cancer; 2006 Jul; 42(10):1369-79. PubMed ID: 16766179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
